Nicholas Investment Partners’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-80,010
| Closed | -$6.56M | – | 238 |
|
|
2024
Q1 | $6.56M | Buy |
+80,010
| New | +$6.56M | 0.67% | 48 |
|
|
2023
Q3 | – | Sell |
-68,905
| Closed | -$1.12M | – | 207 |
|
|
2023
Q2 | $1.12M | Sell |
68,905
-438,165
| -86% | -$7.1M | 0.08% | 160 |
|
|
2023
Q1 | $8.44M | Buy |
+507,070
| New | +$8.44M | 0.64% | 43 |
|
|
2019
Q3 | – | Sell |
-483,951
| Closed | -$4.02M | – | 222 |
|
|
2019
Q2 | $4.02M | Sell |
483,951
-10,779
| -2% | -$89.5K | 0.37% | 99 |
|
|
2019
Q1 | $4.92M | Sell |
494,730
-3,232
| -0.6% | -$32.1K | 0.44% | 70 |
|
|
2018
Q4 | $3.81M | Sell |
497,962
-82,066
| -14% | -$628K | 0.41% | 88 |
|
|
2018
Q3 | $10.1M | Buy |
580,028
+63,237
| +12% | +$1.1M | 0.81% | 25 |
|
|
2018
Q2 | $4.9M | Buy |
+516,791
| New | +$4.9M | 0.34% | 88 |
|